Submission Details
| 510(k) Number | K082661 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 12, 2008 |
| Decision Date | October 06, 2008 |
| Days to Decision | 24 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
K082661 is an FDA 510(k) clearance for the BIOSTREP A, BIOSIGN STREP A, STATUSFIRST STREP A, a Antigens, All Groups, Streptococcus Spp. (Class I — General Controls, product code GTY), submitted by Princeton BioMeditech Corp. (Monmouth Junction, US). The FDA issued a Cleared decision on October 6, 2008, 24 days after receiving the submission on September 12, 2008. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3740.
| 510(k) Number | K082661 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 12, 2008 |
| Decision Date | October 06, 2008 |
| Days to Decision | 24 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
| Product Code | GTY — Antigens, All Groups, Streptococcus Spp. |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3740 |